With this technique, TMPRSS2-ERG fusion was confirmed as the most common genetic alteration in PC, with ERG overexpression in 56% of patients, followed by SPINK1, the second-most common biomarker, showing overexpression in around 10% of PC cases [59]. This evidence concerns the gene ERG and pachyonychia congenita.